Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Human Immunology
|
February 19, 2026
The immunosuppressive role of HLA-G<sup>+</sup> extracellular vesicles in bone marrow of infiltrating tumors: The lesson learned from neuroblastoma and multiple myeloma
Irma Airoldi, Debora Soncini, Danilo Marimpietri, et al.
Cancers
|
May 27, 2026
Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives
Matteo Garibotto, Debora Soncini, Roberto Massimo Lemoli, et al.
International Journal of Cancer
|
October 31, 2009
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha
Enrica Balza, Barbara Carnemolla, Lorenzo Mortara, et al.
Blood Advances
|
June 9, 2026
CRISPR application in hematological disorders: from bench to bedside
Francesco Ladisa, Eugenio Morelli, Debora Soncini, et al.
Frontiers in Immunology
|
September 15, 2025
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1
Debora Soncini, Danilo Marimpietri, Francesco Ladisa, et al.
Current Drug Targets
|
March 28, 2013
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience
Fabrizio Montecucco, Michele Cea, Inga Bauer, et al.
The Journal of Biological Chemistry
|
July 25, 2013
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells
Alessia Grozio, Giovanna Sociali, Laura Sturla, et al.
Plos One
|
February 4, 2010
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression
Alessio Nencioni, Michele Cea, Anna Garuti, et al.
Oncotarget
|
April 25, 2015
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
Irene Caffa, Vito D'Agostino, Patrizia Damonte, et al.
Clinical and Experimental Medicine
|
April 15, 2025
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies
Pasquale Esposito, Lucia Macciò, Antonia Cagnetta, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Human Immunology
|
February 19, 2026
The immunosuppressive role of HLA-G<sup>+</sup> extracellular vesicles in bone marrow of infiltrating tumors: The lesson learned from neuroblastoma and multiple myeloma
Irma Airoldi, Debora Soncini, Danilo Marimpietri, et al.
Cancers
|
May 27, 2026
Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives
Matteo Garibotto, Debora Soncini, Roberto Massimo Lemoli, et al.
International Journal of Cancer
|
October 31, 2009
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha
Enrica Balza, Barbara Carnemolla, Lorenzo Mortara, et al.
Blood Advances
|
June 9, 2026
CRISPR application in hematological disorders: from bench to bedside
Francesco Ladisa, Eugenio Morelli, Debora Soncini, et al.
Frontiers in Immunology
|
September 15, 2025
Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1
Debora Soncini, Danilo Marimpietri, Francesco Ladisa, et al.
Current Drug Targets
|
March 28, 2013
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience
Fabrizio Montecucco, Michele Cea, Inga Bauer, et al.
The Journal of Biological Chemistry
|
July 25, 2013
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells
Alessia Grozio, Giovanna Sociali, Laura Sturla, et al.
Plos One
|
February 4, 2010
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression
Alessio Nencioni, Michele Cea, Anna Garuti, et al.
Oncotarget
|
April 25, 2015
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
Irene Caffa, Vito D'Agostino, Patrizia Damonte, et al.
Clinical and Experimental Medicine
|
April 15, 2025
Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies
Pasquale Esposito, Lucia Macciò, Antonia Cagnetta, et al.
Page
of 4